NCT Number: NCT00608738
Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment
RATIONALE: Gathering information about patients with cancer and cancer-related conditions may help doctors learn more about a patient's needs and help doctors plan the best treatment.
PURPOSE: This clinical trial is studying how well a whole-person-care guide works in identifying patient needs in patients with cancer or complications from cancer treatment.
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
OBJECTIVES:
- To determine what patient needs are detected from NEST13+ interviews of cancer patients and their caregivers.
- To determine the concordance among patient, caregiver, and team goals.
- To determine palliative care services provided.
OUTLINE: Participants are assigned sequentially to 1 of 2 intervention groups.
- Group 1 (NEST13+): Patients and caregivers undergo NEST13+ interviews at the time of admission to Northwestern Memorial Hospital (caregivers answer the NEST13+ interviews from the patient's perspective). A NEST13+ care plan is then derived from both patient and caregiver responses. Research MD or RN presents patient's NEST13+ findings and recommended interventions for integration with actual care. On the day of discharge, patients and caregivers undergo a second NEST13+ interview.
- Group 2 (control): Patients and caregivers undergo a sham interview at the time of admission to Northwestern Memorial Hospital. On the day of discharge, patients and caregivers undergo a NEST13+ interview as in group 1.
Medical charts for all patients are reviewed by a member of the research staff to document needs assessments in domains covered by NEST and to document palliative care-related decisions. Abstracted chart review by blinded experts is also performed to evaluate palliative care quality based on National Comprehensive Cancer Network guidelines.
PROJECTED ACCRUAL: A total of 500 patients and 250 caregivers will be accrued for this study.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Confirmed diagnosis of cancer
- Admitted to one of the two oncology units at Northwestern Memorial Hospital either for treatment of cancer or treatment-related complications
- Complications include, but are not limited to, any of the following:
- Febrile neutropenia
- Infection
- Esophagitis from radiochemotherapy
- Malnutrition
- Spinal cord compression
- Bone pain secondary to metastatic bone disease
- Thrombocytopenia
PATIENT CHARACTERISTICS:
- Able to read and understand English
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Treatment and study plan
medical chart review
OtherQuestionnaire Administration
Otherassessment of therapy complications
Proceduremanagement of therapy complications
ProcedurePrimary outcomes
-
Patient needs detected
-
Concordance among patient, caregiver, and team goals
-
Qualitative and quantitative evaluation of palliative care services provided
Sponsors and collaborators
Lead sponsor
Northwestern University
Other
Registry information
Official study title
Developing a Nested Whole-Person-Care Guide: Screening and Evaluation Steps (American Cancer Society) ACS
Important dates
- Study start
- 2001
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Feb 6, 2008
- Registry last updated
- Jul 10, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy
NCT00770172
Agranulocytosis, Chemotherapeutic Agent Toxicity
Caen, France
View Trial DetailsRituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
NCT01399372
Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity
Birmingham, Alabama, United States
View Trial DetailsRandomized Amifostine For SCCHN
NCT00095927
Carcinoma, Carcinoma, Squamous Cell
Sanford, Maine, United States
View Trial DetailsG-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer
NCT00771433
Agranulocytosis, Breast Cancer
Caen, France
View Trial Details